Focal vs extended ablation in localized prostate cancer with irreversible electroporation; a multi-center randomized controlled trial.

MLA

Scheltema, Matthijs J. V., et al. “Focal vs Extended Ablation in Localized Prostate Cancer with Irreversible Electroporation; a Multi-Center Randomized Controlled Trial.” BMC Cancer, vol. 16, May 2016, pp. 1–9. EBSCOhost, https://doi.org/10.1186/s12885-016-2332-z.

APA

Scheltema, M. J. V., van den Bos, W., de Bruin, D. M., Wijkstra, H., Pilar Laguna, M., de Reijke, T. M., de la Rosette, J. J. M. C. H., Laguna, M. P., & de la Rosette, J. J. (2016). Focal vs extended ablation in localized prostate cancer with irreversible electroporation; a multi-center randomized controlled trial. BMC Cancer, 16, 1–9. https://doi.org/10.1186/s12885-016-2332-z

Chicago

Scheltema, Matthijs J. V., Willemien van den Bos, Daniel M. de Bruin, Hessel Wijkstra, M. Pilar Laguna, Theo M. de Reijke, Jean J. M. C. H. de la Rosette, M Pilar Laguna, and Jean Jmch de la Rosette. 2016. “Focal vs Extended Ablation in Localized Prostate Cancer with Irreversible Electroporation; a Multi-Center Randomized Controlled Trial.” BMC Cancer 16 (May): 1–9. doi:10.1186/s12885-016-2332-z.